13th WRIB
Event details
| Website: | |
| Location: | Hyatt Regency New Orleans, 601 Loyola Ave, New Orleans, United States, America |
While the 13th WRIB is bulit on its previous success and continues its well-established tradition to provide Novel Solutions in Drug Discovery/Development and promote Innovation in Method Development in Bioanalysis, Biomarkers and Immunogenicity, the 2019 edition will also have a very special focus on the ICH M10 Draft Bioanalytical Method Validation Guideline (expected issuance for public consultation: Jan. 2019). Let’s work altogether to provide official Recommendations to ICH in the 2019 White Paper in Bioanalysis!
What makes WRIB special?
In this busy and fast paced environment, it is great to attend a conference that organizes everything for you so all you need to do is to focus on your learning:
- No need to rush at last minute to print speakers/course slides before you travel… At WRIB you’ll receive a program book with all the materials you need;
- No need to take notes on a blank paper or on your computer/ipad… At WRIB you have the slides of all the speakers in the program book, so take your notes right on the slides where they belong to;
- No need to look for which session to follow or scramble from one room to another to catch different speakers in multiple parallel session… At WRIB all sessions are sequential so just sit and relax enjoying the sessions with your coffee/tea
- No need to run to look for a restaurant/cafe to eat breakfast or lunch… At WRIB, food and snacks and wine and beers are all included for you every single day so you can just focused on learning and networking
Poster: PEGylation: A Pharmacological Advantage and a Bioanalytical Challenge Presenter: Clara Branda, PhD
Princiap Investigator
Poster: LC-MS/MS Bioanalysis to Support Preclinical and Clinical Drug Development for Affibody Protein
Presenter: Johannes Stanta, PhD
Scientific Manager, Bioanalysis (Europe)
For more information, please click here!
We are hosting a reception on Wednesday, April 11th at 6:30pm within walking distance of the conference hotel. We will be serving heavy hors d’oeuvres and cocktails with live music entertainment. If you would like to join us for this special event, Register Here!
Come and meet the team on stand 45.
The 13th WRIB will be built on the success of the previous meetings, especially the 12th WRIB where over 900 professionals representing pharmaceutical/biopharmaceutical companies, CROs and multiple regulatory agencies convened to discuss current topics of interest in bioanalysis, biomarkers, and immunogenicity. High Quality, better compliance to regulations and scientific excellence are always the foundations of this workshop.
Poster
Detection of Anti-Drug Antibody (ADA) Using Single Molecule Counting (SMC™) Technology
Stop by our booth to speak with us about your bioanalytical needs. LEARN MORE
Our Pharmaceutical Services Senior Director, Dr. Mike Buonarati, will be presenting on ICH and LCMS:
10:30 – 11:00 am
Stability Evaluation of Higher Concentration QCs (>ULOQ)
Dr. Mike Buonarati, Senior Director, Intertek
Dr. Lauren Stevenson, Sr. Director Development Biomarkers & Bioanalytical Sciences, Biogen
2:15 pm – 2:35 pm
Reporting of Re-integrated Chromatograms & Study Report Re-injected runs with Results
Dr. Mike Buonarati, Senior Director, Intertek
4:55 – 5:25 pm
Importance of Internal Standard Variability
Dr. Mike Buonarati, Senior Director, Intertek
Dr. Arindam Dasgupta, Deputy Director, US FDA
We hope to see you there!
Join BioAgilytix’s Immunogenicity Experts at the 13th WRIB 2019
Leading scientists from BioAgilytix will be attending the conference to discuss novel solutions in drug discovery and development as well as innovation in method development in bioanalysis, biomarkers, and immunogenicity. Meet with our industry experts to learn how BioAgilytix can apply our proven expertise to your complex large molecule project.
JOIN US FOR THE FOLLOWING SESSIONS:
arno kromminga
Dr. Afshin Safavi, our Founder and Board Member, will be presenting and participating in a panel discussion during the 13th WRIB 2019. His sessions will focus on the variations in biomarker assessment among different regulatory guidances as well as the challenges associated with the development and validation of NAb assays in biosimilar assessments.
Understanding of the Biology of Biomarkers for Successful BAV
Presentation
Monday, April 1
Novel Guidelines & White Papers for BAV
Panel Discussion
Monday, April 1
WRIB Welcome Reception
Come join the party!
As the premiere sponsor at WRIB, we look forward to seeing you at the Welcome Reception on Monday night at 5:30pm at the 8 Block Kitchen and Bar.
Be sure to grab your playing card at the reception and bring it to the Waters booth to reveal your prize (Three Grand Prizes Up for Grabs!)
_____________________________________________________________________
Check out these scientific poster presentations:
Hybrid LC–MS/MS for Quantification of Infliximab in Crohn’s Disease Patient Samples: Does it add value?
Poster Number: Day2-P06
Development of a SPE LC–MS/MS Method for the Bioanalytical Quantification of Pramlintide from serum
Poster Number: Day2-P09
_____________________________________________________________________
On the Exhibit Floor
We encourage you to visit Booth #21 to talk to our experts and learn the secrets behind achieving optimal quantitative performance – starting with new developments in sample handling through to LC-MS method development – we’ve got you covered!
In the booth Tuesday, Wednesday, and Thursday from 3:00pm-4:00pm come Meet the Scientists who are developing the research and technologies that support your bioanalysis work.